The last few years have seen dramatic progress in the development of HIV pre-exposure prophylaxis (PrEP). These developments have been met by ethical concerns. HIV interventions are often thought to be ethically difficult. In a context which includes disagreements over human rights, controversies over testing policies, and questions about sexual morality and individual responsibility, PrEP has been seen as an ethically complex intervention. We argue that this is mistaken, and that in fact, PrEP does not raise new ethical concerns. Some of the questions posed by PrEP are not specific to HIV prophylaxis, but simply standard public health considerations about resource allocation and striking a balance between individual benefit and public good...
Abstract Though many women in need of access to HIV preventive regimes are pregnant, there is a dear...
Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against H...
Despite high levels of efficacy, the implementation of preexposure prophylaxis (PrEP) as a strategy ...
Pre-exposure prophylaxis (PrEP) is the daily use of antiretrovirals to prevent human immunodeficienc...
Several ethical decision making processes help frame the series of actions leading to prevention of ...
There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likel...
BACKGROUND. Pre-exposure prophylaxis (PrEP) is an experimental HIV prevention approach whereby antir...
There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likel...
Civil society-led movements transformed global AIDS action from deep skepticism about extending anti...
With current estimates suggesting that 33 million people are currently living with HIV globally and ...
Background and aimsPre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medicin...
On July 16, 2012, emtricitabine/tenofovir (Truvada) became the first drug approved by the US Food an...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or PrEP, is the use of antiretroviral medicin...
Two multinational clinical trials have shown safety and efficacy of long-acting injectable cabotegra...
Background: In the United States, human immunodeficiency virus (HIV) remains a substantial public he...
Abstract Though many women in need of access to HIV preventive regimes are pregnant, there is a dear...
Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against H...
Despite high levels of efficacy, the implementation of preexposure prophylaxis (PrEP) as a strategy ...
Pre-exposure prophylaxis (PrEP) is the daily use of antiretrovirals to prevent human immunodeficienc...
Several ethical decision making processes help frame the series of actions leading to prevention of ...
There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likel...
BACKGROUND. Pre-exposure prophylaxis (PrEP) is an experimental HIV prevention approach whereby antir...
There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likel...
Civil society-led movements transformed global AIDS action from deep skepticism about extending anti...
With current estimates suggesting that 33 million people are currently living with HIV globally and ...
Background and aimsPre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medicin...
On July 16, 2012, emtricitabine/tenofovir (Truvada) became the first drug approved by the US Food an...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or PrEP, is the use of antiretroviral medicin...
Two multinational clinical trials have shown safety and efficacy of long-acting injectable cabotegra...
Background: In the United States, human immunodeficiency virus (HIV) remains a substantial public he...
Abstract Though many women in need of access to HIV preventive regimes are pregnant, there is a dear...
Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against H...
Despite high levels of efficacy, the implementation of preexposure prophylaxis (PrEP) as a strategy ...